Disease | thromboembolism |
Phenotype | C0730285|diabetic macular edema |
Sentences | 1 |
PubMedID- 22829940 | Intravitreal anti-vegf significantly decreased the risk of arterial thromboembolic events by 32% in patients with diabetic macular edema, with the 95% confidence intervals of 6% to 64%; no difference in this risk was detected in patients with neovascular age-related macular degeneration and retinal vein occlusion. |
Page: 1